Literature DB >> 12445176

Macro-aspartate aminotransferase in a female with antibodies to hepatitis C virus.

John Collins1, Detlef Ritter, Bruce R Bacon, Michael Landt, Michael H Creer.   

Abstract

Persistent elevation of aspartate aminotransferase (AST) activity in serum due to the presence of a macroenzyme form of AST (macro-AST) may lead to diagnostic confusion in many clinical conditions, particularly those associated with chronic liver disease. We describe a case of macro-AST arising in an adult female with a false-positive hepatitis C virus (HCV) RNA test result that was not accompanied by other biochemical or histologic evidence of liver disease. The presence of macro-AST in serum was confirmed utilizing size-exclusion, high performance liquid chromatography (HPLC) and Protein G-agarose beads to precipitate immune complexes of AST and immunoglobulin G followed by centrifugation and AST activity measurements in the supernatant. A brief review of the clinical enzymology of AST and methods used to quantify serum macro-AST activity is provided.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445176     DOI: 10.1034/j.1600-0676.2002.01689.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  4 in total

1.  Macro-aspartate aminotransferase: two-year follow-up of three patients in China.

Authors:  Zheng Yu; Yu Wang; Lijuan Feng; Jidong Jia
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

2.  Isolated aspartate aminotransferase elevation: think macro-AST.

Authors:  Maximilian Lee; Pietro Vajro; Emmet B Keeffe
Journal:  Dig Dis Sci       Date:  2011-01-19       Impact factor: 3.199

3.  Distribution of serum concentrations reported for macroenzyme aspartate aminotransferase (macro-AST).

Authors:  Asa S Rubin; David A Sass; Douglas F Stickle
Journal:  Pract Lab Med       Date:  2017-05-17

Review 4.  Persistent elevation of aspartate aminotransferase in a child after incomplete Kawasaki disease: a case report and literature review.

Authors:  Pejman Rohani; Farid Imanzadeh; Aliakbar Sayyari; Maryam Kazemi Aghdam; Reza Shiari
Journal:  BMC Pediatr       Date:  2020-02-17       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.